title: Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity.
abstract: Adiponectin, the most abundant hormone produced by adipose tissue, circulates in 3 isoforms, including high molecular weight (HMW) adiponectin. The latter has been suggested to be a better predictor of metabolic disturbances and insulin resistance associated with obesity. This study investigated changes in total and HMW adiponectin, resistin, and homeostasis model assessment (HOMA) during a 9-month in-patient treatment program based on physical exercise and a balanced diet in 32 severely obese adolescents. Total and HMW adiponectin, resistin, and HOMA were measured at baseline (month 0) and during the program (months 3, 6, 9). In addition, a control group of 15 teenagers served as a reference for the baseline assessments. At baseline, HMW adiponectin was more markedly decreased in obese adolescents than total adiponectin, and both were lower than in controls. Conversely, resistin and HOMA were higher in obese adolescents. During the program, there was a significant change in body composition and improved insulin sensitivity among obese teenagers. In addition, HMW adiponectin and the ratio of HMW-to-total adiponectin increased throughout the study, whereas total adiponectin only increased up until the sixth month. On the contrary, resistin did not show any significant change. In obese adolescents, a long-term combination of aerobic exercise and a balanced diet, inducing change in body composition and improved insulin sensitivity, markedly increased HMW adiponectin compared with total adiponectin, without any change in resistin concentrations. Our results thus suggest that the determination of HMW adiponectin could be more useful than measurement of total adiponectin in clinical settings.
authors.affiliation: Université de Franche-Comté, Besançon, France. carine.gueugnon@yahoo.fr
authors.forename: Carine
authors.initials: C
authors.lastname: Gueugnon
authors.forename: Fabienne
authors.initials: F
authors.lastname: Mougin
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Simon-Rigaud
authors.forename: Jacques
authors.initials: J
authors.lastname: Regnard
authors.forename: Véronique
authors.initials: V
authors.lastname: Nègre
authors.forename: Gilles
authors.initials: G
authors.lastname: Dumoulin
mesh_terms: D052242:Adiponectin / Q000097:blood* / Q000737:chemistry; D000293:Adolescent; D016497:Adolescent Health Services / Q000458:organization & administration; D004038:Diet, Reducing; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D007297:Inpatients; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008970:Molecular Weight; D009767:Obesity, Morbid / Q000178:diet therapy / Q000378:metabolism / Q000503:physiopathology; D015397:Program Evaluation; D052243:Resistin / Q000097:blood*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin; D007328:Insulin; C499624:RETN protein, human; D052243:Resistin